Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,318
Sort by:
2017 Europe Hemostasis Diagnostics Market: Analyzer and Reagent Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Spain, UK
US$ 17,730.00
... and market shares of major instrument and reagent suppliers. Competitive Assessments Extensive strategic profiles of major suppliers and emerging market entrants. Market Segmentation Analysis Comprehensive market segmentation analysis, including: Hospitals Commercial/Private Laboratories ...
March 2017
500 pages
2017 Nucleic Acid Testing/NAT World Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Opportunities--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 31,050.00
... Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Ten-year test volume and sales projections for over 30 NAT assays ... , Tecan and other suppliers.- Extensive review of NAT technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...
March 2017
1398 pages
2017 Hemostasis Diagnostics Market: Analyzer and Reagent Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US
US$ 31,050.00
... , as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies ... antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the global coagulation diagnostics practice during ...
March 2017
650 pages
2017 Europe Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Spain, UK
US$ 17,730.00
... tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and ...
March 2017
820 pages
2017 France Nucleic Acid Testing/NAT Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Opportunities--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 6,030.00
... following categories: Infectious Diseases Cancer Forensic Testing Genetic Diseases Paternity Testing/HLA Typing Review of testing methodologies and instrumentation technologies. Feature comparison ... and market shares of leading suppliers. Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and ...
March 2017
1125 pages
2017 Germany Nucleic Acid Testing/NAT Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Opportunities--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 6,030.00
... following categories: Infectious Diseases Cancer Forensic Testing Genetic Diseases Paternity Testing/HLA Typing Review of testing methodologies and instrumentation technologies. Feature comparison ... and market shares of leading suppliers. Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and ...
March 2017
1125 pages
2017 Japan Nucleic Acid Testing/NAT Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Opportunities--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 7,650.00
... following categories: Infectious Diseases Cancer Forensic Testing Genetic Diseases Paternity Testing/HLA Typing Review of testing methodologies and instrumentation technologies. Feature comparison ... and market shares of leading suppliers. Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and ...
March 2017
1126 pages
2017 Spain Nucleic Acid Testing/NAT Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Opportunities--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 6,030.00
... following categories: Infectious Diseases Cancer Forensic Testing Genetic Diseases Paternity Testing/HLA Typing Review of testing methodologies and instrumentation technologies. Feature comparison ... and market shares of leading suppliers. Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and ...
March 2017
1117 pages
2017 U.K. Nucleic Acid Testing/NAT Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Opportunities--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 6,030.00
... following categories: Infectious Diseases Cancer Forensic Testing Genetic Diseases Paternity Testing/HLA Typing Review of testing methodologies and instrumentation technologies. Feature comparison ... and market shares of leading suppliers. Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and ...
March 2017
1122 pages
2017 U.S. Nucleic Acid Testing/NAT Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Opportunities--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 8,550.00
... following categories: Infectious Diseases Cancer Forensic Testing Genetic Diseases Paternity Testing/HLA Typing Review of testing methodologies and instrumentation technologies. Feature comparison ... and market shares of leading suppliers. Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and ...
March 2017
1157 pages
2017 Europe Nucleic Acid Testing/NAT Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Opportunities--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 17,730.00
Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. This new 1,273- ... in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features ...
March 2017
1273 pages
2017 Italy Nucleic Acid Testing/NAT Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Opportunities--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 6,030.00
... following categories: Infectious Diseases Cancer Forensic Testing Genetic Diseases Paternity Testing/HLA Typing Review of testing methodologies and instrumentation technologies. Feature comparison ... and market shares of leading suppliers. Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and ...
March 2017
1117 pages
2017 Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US
US$ 31,275.00
... Biochemical Markers Growth Factors Colony Stimulating Factors Hormones Immunohistochemical Stains Lymphokines Supplier Shares, Sales and Volume Forecasts Sales and market shares of major cancer diagnostic product suppliers by individual test and country. Five-year test volume and sales forecasts for major tumor markers ...
March 2017
1200 pages
Hematology and Flow Cytometry 2021: Analyzers and Reagents--Supplier Shares and Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review
US$ 31,050.00
... , Italy, Japan, Spain, UK, USA Worldwide Market Overview Facilities performing hematology and flow cytometry testing by country. Test volume and sales projections by country ... study reviews current instrumentation technologies and compares features of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers. The report features ...
March 2017
700 pages
Microbiology 2021: Supplier Shares and Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review--Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics
US$ 31,950.00
... forecasts, supplier shares) $22,400. VPGMarketResearch.coms new report is a seven-country strategic analysis of the major business opportunities emerging in the automated microbiology market ... for the microbiology market. Global listings of companies developing or marketing microbiology products by individual test. Competitive Assessments Strategic assessments of major suppliers and emerging ...
March 2017
821 pages
Cancer Diagnostics 2021: Supplier Shares and Strategies, Country Segment Forecasts, Tehnology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 31,275.00
... Current and Emerging Cancer Diagnostic Test Oncogenes Biochemical Markers Growth Factors Colony Stimulating Factors Hormones Immunohistochemical Stains Lymphokines Supplier Shares, Sales and Volume Forecasts Sales and market shares of major cancer diagnostic product suppliers by individual test and country ...
March 2017
1200 pages
Hemostasis Diagnostics 2021: Analyzers and Reagents--Supplier Shares and Strategies, Country Segment Forecasts, Tehnology Trends, Emerging Opportunities
US$ 31,050.00
... antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the global coagulation diagnostics practice during the ... established and emerging procedures. Comparison of automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and ...
March 2017
650 pages
Immunohematology and NAT 2021: Analyzers and Reagents--Supplier Shares and Strategies, Country Segment Forecasts, Tehnology Trends, Emerging Opportunities
US$ 31,950.00
... Disease Screening Tests AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV ... emerging blood banking tests. Review of automated and semi-automated analyzers, including their operating characteristics, features, and selling prices. Technology ...
March 2017
775 pages
2017-2021 Emerging Opportunities in the French Hospital Infectious Disease Testing Market
US$ 4,005.00
... of leading suppliers by test. Emerging diagnostic technologies and their potential market applications. Product development opportunities. Profiles of current and emerging suppliers, including their ... -how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 897 pages and ...
March 2017
897 pages
2017-2021 Emerging Opportunities in the German Hospital Infectious Disease Testing Market
US$ 4,005.00
... shares of leading suppliers. Emerging diagnostic technologies and their potential market applications. Product development opportunities. Profiles of current and emerging suppliers, including their ... -how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 897 pages and ...
March 2017
897 pages
2017-2021 Emerging Opportunities in the Italian Hospital Infectious Disease Testing Market
US$ 4,005.00
... shares of leading suppliers. Emerging diagnostic technologies and their potential market applications. Product development opportunities. Profiles of current and emerging suppliers, including their ... -how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 887 pages and ...
March 2017
887 pages
2017-2021 Emerging Opportunities in the Japanese Hospital Infectious Disease Testing Market
US$ 5,220.00
... shares of leading suppliers. Emerging diagnostic technologies and their potential market applications. Product development opportunities. Profiles of current and emerging suppliers, including their ... -how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 891 pages and ...
March 2017
891 pages
2017-2021 Emerging Opportunities in the Spanish Hospital Infectious Disease Testing Market
US$ 4,005.00
... shares of leading suppliers. Emerging diagnostic technologies and their potential market applications. Product development opportunities. Profiles of current and emerging suppliers, including their ... -how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 880 pages and ...
March 2017
880 pages
2017-2021 Emerging Opportunities in the UK Hospital Infectious Disease Testing Market
US$ 4,005.00
... shares of leading suppliers. Emerging diagnostic technologies and their potential market applications. Product development opportunities. Profiles of current and emerging suppliers, including their ... -how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 886 pages and ...
March 2017
886 pages
2017-2021 Emerging Opportunities in the US Hospital Infectious Disease Testing Market
US$ 6,120.00
... of leading suppliers by test. Emerging diagnostic technologies and their potential market applications. Product development opportunities. Profiles of current and emerging suppliers, including their ... -how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 997 pages and ...
March 2017
997 pages
2017-2021 Emerging Point-of-Care/POC in the US Drugs of Abuse Testing Market: Physician Offices, Emergency Rooms, Ambulatory Care Centers--Supplier Shares, Competitive Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review
US$ 2,250.00
... of the POC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities ... Offices/Group Practices Emergency Rooms Ambulatory Care Centers Analysis of drugs of abuse procedures Competitive Assessments Assessments of major POC suppliers and emerging market entrants ...
March 2017
165 pages
2017-2021 Emerging US Point-of-Care/POC Lipid Testing Market: Physician Offices, Emergency Rooms, Ambulatory Care Centers--Supplier Shares, Competitive Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review
US$ 2,610.00
... of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for ... segment: Physician Offices/Group Practices Emergency Rooms Ambulatory Care Centers Competitive Assessments Assessments of major POC suppliers and emerging market entrants, including their ...
March 2017
305 pages
2017-2021 Europe Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Country Sales Segment Forecasts for 10 Immunodiagnostic and NAT Procedures
US$ 6,210.00
... $6,900. DataPack (test volumes, sales forecasts, supplier shares) $4,500. The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology ...
March 2017
295 pages
